No Record Found
Sector
PharmaceuticalsOpen
₹377Prev. Close
₹377.25Turnover(Lac.)
₹30.88Day's High
₹388.05Day's Low
₹37752 Week's High
₹63052 Week's Low
₹292.95Book Value
₹194.82Face Value
₹10Mkt Cap (₹ Cr.)
520.61P/E
57.93EPS
6.51Divi. Yield
0.2512 Aug 2025
12:00 AM
BookCloser
26 Feb 2025
12:00 AM
EGM
12 Aug 2025
12:00 AM
AGM
Announcement Date: 12 Aug, 2025
7 Aug 2025
12:00 AM
Board Meeting
Agenda : Audited Result
30 May 2025
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 19 Sep, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 12.71 | 12.71 | 13.78 | 12.22 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 204.92 | 196.49 | 180.02 | 135.82 |
Net Worth | 217.63 | 209.2 | 193.8 | 148.04 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 110.14 | 117.34 | 111.5 | 82.45 |
yoy growth (%) | -6.13 | 5.23 | 35.23 | 22.56 |
Raw materials | -66.87 | -72.95 | -67.65 | -49.2 |
As % of sales | 60.71 | 62.17 | 60.67 | 59.67 |
Employee costs | -8.79 | -9.29 | -9.05 | -6.65 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 16.75 | 16.6 | 13.9 | 6.35 |
Depreciation | -2.51 | -2.49 | -2.05 | -1.92 |
Tax paid | -4.26 | -4.34 | -3.78 | -1.19 |
Working capital | -1.38 | -8.09 | 38.28 | 6.51 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -6.13 | 5.23 | 35.23 | 22.56 |
Op profit growth | 10.23 | 7.79 | 49.71 | 119.69 |
EBIT growth | 3.74 | 5.29 | 73.66 | 146.26 |
Net profit growth | 1.85 | 21.22 | 95.97 | 973.02 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 162.55 | 179.31 | 140.87 | 115.45 | 112.72 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 162.55 | 179.31 | 140.87 | 115.45 | 112.72 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 6.24 | 2.33 | 2.46 | 1.72 | 0.75 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,706.4 | 82.24 | 4,09,626.46 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,804 | 77.34 | 1,80,668.62 | 557 | 0.44 | 2,357 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,628.3 | 61.77 | 1,22,787.57 | 551 | 0.17 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,511.5 | 23.49 | 1,22,102.7 | 1,210.53 | 1.06 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,196 | 18.5 | 99,857.36 | 387.3 | 0.67 | 4,602.9 | 377.57 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Sanjay Bansal
Chairman (Non-Executive)
Rahul Bishnoi
Non Executive Director
Ashwani Kumar Sharma
Independent Director
Harish Pande
Non Executive Director
S K Singh
Independent Director
Arun Kumar
Company Sec. & Compli. Officer
Parul Choudhary
Independent Director
Sumita Dwivedi
Non Executive Director
Vimal Kumar Shrawat.
Independent Director
Sangeeta Bishnoi
Independent Director
Ravi Kumar Bansal
1506 Chiranjiv Tower 43,
Nehru Place,
New Delhi - 110019
Tel: 91-11-47589500
Website: http://www.medicamen.com
Email: cs@medicamen.com
Narang Tower,
44 Community Centre, Naraina Ind Area,
New Delhi-110028
Tel: 91-11-41410592-94
Website: www.linkintime.co.in
Email: delhi@linkintime.co.in
Summary
A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as w...
Read More
Reports by Medicamen Biotech Ltd
What is the Medicamen Biotech Ltd share price today?
What is the Market Cap of Medicamen Biotech Ltd?
What is the PE and PB ratio of Medicamen Biotech Ltd?
What is the 52 Week High and Low of Medicamen Biotech Ltd?
What is the CAGR of Medicamen Biotech Ltd?
What is the shareholding pattern of Medicamen Biotech Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.